Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (13994)	7/5/2000 2:35:02 PM
From: Bluegreen	Respond to of 17367

Cacaito, I have always just said hopefully Neuprex can be added to conventional antibiotics in treatment of Gram Neg infections. I have been screaming it since I started posting. I rely totally on the Baboon study in the SIGNIFICANT reduction of Bacteremia. NO PLACEBO HAS EVER BEEN SHOWN TO DO THAT WITH CONVENTIONAL ANTIBIOTICS, HAS IT???????? Maybe I dream too small. Listen, you and I both know that there is almost no chance that one single PRODUCT WILL BRING YOU FROM THE DEPTHS OF FULL BLOWN SEPSIS!!!!!!! ONCE THAT CASCADE TAKES HOLD......well you have seen it many times I'm sure. TOO MANY VARIABLES IN THE CASCADE.